NDC 68788-9809-01 - LISINOPRIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-9809
- Requested NDC
- 68788-9809-01
- Package NDCs from labels
- 68788-9809-3, 68788-9809-6, 68788-9809-9, 68788-9809-1, 68788-9809-01
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Effective date
- 2026-05-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS USP | Preferred Pharmaceuticals, Inc. | 2026-05-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-9809-1 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 100 in 1 BOTTLE | TABLET | 100 | 13 | |
| 68788-9809-3 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET | 30 | 13 | |
| 68788-9809-6 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 60 in 1 BOTTLE | TABLET | 60 | 13 | |
| 68788-9809-9 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET | 90 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-9809 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] | 11 | Current NDC, Legacy NDC, 4 package rows | 20240621_5aa18b0b-4688-493a-a5ae-cb056ea6c0e3.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 89ce2fb1-330c-45f9-bd37-b402feea9378 | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| triamterene and hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 27b8f965-d73f-411c-aae6-bcae6e281113 | 2023-10-23 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NCS HealthCare of KY, LLC dba Vangard Labs | d6b933c6-f5f8-406a-84d6-b22c6040482a | 2023-10-19 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 24cba606-263f-46dc-a4dc-fddc729c0f4b | 2023-10-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| Alumina | ALUMINUM OXIDE | Boiron | 84266aa8-b80c-a2a5-e053-2991aa0a68e0 | 2023-10-18 | LMI26O6933 | |
| Alumina | ALUMINUM OXIDE | Boiron | 8426b2bb-4401-9015-e053-2991aa0a0993 | 2023-10-18 | LMI26O6933 | |
| Alumina | ALUMINUM OXIDE | Boiron | 8426e977-2b24-fdf4-e053-2a91aa0a7c39 | 2023-10-18 | LMI26O6933 | |
| Alumina | ALUMINUM OXIDE | Boiron | 84b528ab-23f7-e42c-e053-2991aa0acc4d | 2023-10-18 | LMI26O6933 | |
| Lisinopril | LISINOPRIL | Aphena Pharma Solutions - Tennessee, LLC | a79a034d-7bbb-4b05-b8fc-8ebf09f33c0c | 2023-10-04 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 9dd2f58b-d143-4d0c-a298-6d9390e6187a | 2023-10-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Benazepril Hydrochloride and Hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Glenmark Pharmaceuticals Inc., USA | 51b0aed8-a229-4d2c-8fdf-aa957fddc41b | 2023-09-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | ba452478-f40c-446e-b61d-388379a55efd | 2023-09-18 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | e80f232c-c1c4-4524-a0a5-d23ee0d1f3b7 | 2023-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | Aphena Pharma Solutions - Tennessee, LLC | 719c4db7-ccbe-4779-baa7-a3c461f3aa52 | 2023-09-12 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | b9e1bed7-fef9-434a-92f9-b70941176e3e | 2023-09-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| triamterene and hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | 1af80800-e7a5-42e5-aa6c-3f61aff4a77b | 2023-08-31 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| triamterene and hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Zydus Pharmaceuticals (USA) Inc. | fa69eeb8-ec82-4be1-8cb7-f64094ed957c | 2023-08-26 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 1bb00980-eeea-4722-b010-e208f3ec2214 | 2023-08-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | Aphena Pharma Solutions - Tennessee, LLC | 021831ab-dfeb-40fc-aede-4aa1fbb8d918 | 2023-08-18 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | 3OWL53L36A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.